LGD-4033 is a potent, selective androgen receptor modulator that has been designed to treat subjects [§2 - T.O.U.] who suffer from muscle wasting diseases by elevating lean muscle mass [§2 - T.O.U.].
GW501516 is a potent PPARβ (peroxisome proliferator-activated receptor) agonist that exhibits 1,000-fold more selectivity than existing subtypes and has been shown to regulate gene expression in lipid catabolism.
